Clinical Trial Update: A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating safety, tolerability, and efficacy of elamipretide in Barth syndrome completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barth Syndrome

Drugs mentioned

• Elamipretide (elamipretide)

Snippet

Sponsor: Stealth BioTherapeutics Inc. | Conditions: Barth Syndrome | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-04-16